Identification of truncating mutations in HPCX1 families with NMD technology

ABSTRACT: In this study, nonsense-mediated mRNA decay (NMD) inhibition was used for the discovery of truncating mutations. Six prostate cancer (PRCA) patients and their healthy brothers were selected from a group of HPCX1-linked families. mRNA was isolated from their lymphoblastic cells after pharmacological treatment. Expression analyses were done using Agilent 44K oligoarrays, and selected genes were screened for mutations by sequencing. In order to identify genes containing inactivating mutations in the Xq27-q28 region, an NMD microarray analysis with Agilent 44K Whole Human Genome oligonucleotide microarrays was performed in the families showing the strongest linkage to HPCX1. Five families were chosen with 6 affected and 6 healthy controls. Lymphoblastoid cell lines were derived from whole bloo

ORGANISM(S): Homo sapiens

SUBMITTER: Henna Mattila 

PROVIDER: E-GEOD-24204 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress